INHIBITORS OF INFLUENZA VIRUSES REPLICATION

Polymorphic forms of Compound (1) or a pharmaceutically acceptable salt thereof, wherein Compound (1) is represented by the following structural formula: are Form A of HCl salt of Compound (1).½H2O, Form F of HCl salt of Compound (1).3H2O, Form D of HCl salt of Compound (1), Form A of Compound (1),...

Full description

Saved in:
Bibliographic Details
Main Authors Jones Steven, Macikenas Dainius, Jurkauskas Valdas, Shi Yi, Tsai Wanjung, Asmal Mohammed, Medek Ales, Mudunuri Praveen, Nti-Addae Kwame W, Ledeboer Mark Willem, O'Neil Simon Adam, Byrn Randal, Waldo Michael, Van Alsten John Gregg, Robertson Sarah Marie
Format Patent
LanguageEnglish
Published 01.09.2016
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Polymorphic forms of Compound (1) or a pharmaceutically acceptable salt thereof, wherein Compound (1) is represented by the following structural formula: are Form A of HCl salt of Compound (1).½H2O, Form F of HCl salt of Compound (1).3H2O, Form D of HCl salt of Compound (1), Form A of Compound (1), and Form A of tosylate salt of Compound (1). Such polymorphic forms are employed for treating influenza, inhibiting the replication of influenza viruses, or reducing the amount of influenza viruses in a biological sample or in a subject.
Bibliography:Application Number: US201615150459